Furthermore, in a subcohort of the Cardiovascular Health Study (n = 2026), baseline fasting plasma IGFBP-1 was similar in adults aged 65 years or older that later developed stroke compared with control subjects, and IGFBP-1 did not predict the risk of stroke [23]. This evidence concerns the gene IGFBP1 and stroke disorder.